MeSH Review:
Clot Retraction
- PTP-1B is an essential positive regulator of platelet integrin signaling. Arias-Salgado, E.G., Haj, F., Dubois, C., Moran, B., Kasirer-Friede, A., Furie, B.C., Furie, B., Neel, B.G., Shattil, S.J. J. Cell Biol. (2005)
- Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3. Chen, Y.P., O'Toole, T.E., Leong, L., Liu, B.Q., Diaz-Gonzalez, F., Ginsberg, M.H. Blood (1995)
- Platelet function in chronic leukemias. Naresh, K.N., Sivasankaran, P., Veliath, A.J. Indian journal of cancer. (1992)
- Impaired clot retraction in thrombocytopenia due to methyldopa. Polk, O.D., Kletter, G.G., Smith, J., Castro, O. South. Med. J. (1982)
- Platelet function in acute leukemias. Naresh, K.N., Sivasankaran, P., Veliath, A.J. The Journal of the Association of Physicians of India. (1993)
- Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. Di Minno, G., Cerbone, A.M., Mattioli, P.L., Turco, S., Iovine, C., Mancini, M. J. Clin. Invest. (1985)
- Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. Holmbäck, K., Danton, M.J., Suh, T.T., Daugherty, C.C., Degen, J.L. EMBO J. (1996)
- A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects. Kiyoi, T., Tomiyama, Y., Honda, S., Tadokoro, S., Arai, M., Kashiwagi, H., Kosugi, S., Kato, H., Kurata, Y., Matsuzawa, Y. Blood (2003)
- Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization. Mondoro, T.H., White, M.M., Jennings, L.K. Blood (2000)
- The role of putative fibrinogen Aalpha-, Bbeta-, and GammaA-chain integrin binding sites in endothelial cell-mediated clot retraction. Smith, R.A., Mosesson, M.W., Rooney, M.M., Lord, S.T., Daniels, A.U., Gartner, T.K. J. Biol. Chem. (1997)
- Inhibition of platelet aggregation by a new agent, Ticlopidine. Ashida, S.I., Abiko, Y. Thromb. Haemost. (1979)
- Comparison of fibrin clot retraction with other transformation parameters after hydridization of normal and established cell lines. Curatolo, L., Azzarone, B., Fally-Crépin, C., Morasca, L., Macieira-Coelho, A. Int. J. Cancer (1983)
- Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation. Osdoit, S., Rosa, J.P. J. Biol. Chem. (2001)
- Ionophore a 23187: some effects on platelet aggregation and clot retraction. Bottecchia, D., Fantin, G., Gruppo, F., Nassuato, G. Haemostasis (1976)
- Possible mechanisms of epinephrine actions in quin-2-loaded platelets refractory to arachidonic acid. Rao, G.H., Gerrard, J.M., Murthy, M., White, J.G. Biochem. Med. Metab. Biol. (1993)
- The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction. Rooney, M.M., Farrell, D.H., van Hemel, B.M., de Groot, P.G., Lord, S.T. Blood (1998)
- Defective platelet function following the administration of penicillin compounds. Brown, C.H., Bradshaw, M.J., Natelson, E.A., Alfrey, C.P., Williams, T.W. Blood (1976)
- RhoA and the function of platelet integrin alphaIIbbeta3. Leng, L., Kashiwagi, H., Ren, X.D., Shattil, S.J. Blood (1998)
- Effect of propranolol on platelet function. Weksler, B.B., Gillick, M., Pink, J. Blood (1977)
- Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots. Schoenwaelder, S.M., Yuan, Y., Cooray, P., Salem, H.H., Jackson, S.P. J. Biol. Chem. (1997)
- A CD9, alphaIIbbeta3, integrin-associated protein, and GPIb/V/IX complex on the surface of human platelets is influenced by alphaIIbbeta3 conformational states. Longhurst, C.M., White, M.M., Wilkinson, D.A., Jennings, L.K. Eur. J. Biochem. (1999)
- Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction. Kunitada, S., FitzGerald, G.A., Fitzgerald, D.J. Blood (1992)
- Antibodies to GPIIb alpha (300-312) inhibit Fg binding, clot retraction, and platelet adhesion to multiple ligands. Taylor, D.B., Derrick, J.M., Gartner, T.K. Proc. Soc. Exp. Biol. Med. (1994)
- Force monitoring of clot retraction during DDAVP therapy for the qualitative platelet disorder of uraemia: report of a case. Carr, M.E., Zekert, S.L. Blood Coagul. Fibrinolysis (1991)